Preventive Screening Schedules - NCLEX Rn

1. A 74-year-old man with chronic kidney disease stage 3 and hyperlipidemia presents for an annual visit. He quit smoking 20 years ago (30 pack-year history) and has no chest pain or dyspnea. He states he prefers to avoid invasive procedures unless clearly needed. The nurse should recommend which preventive test based on the client's age and history?
   Answer: One-time abdominal aortic aneurysm ultrasound screening because he is a man aged 65–75 with a history of smoking This question tests understanding of preventive screening schedules in health promotion, focusing on age- and risk-based vascular and cancer screenings. USPSTF guidelines recommend one-time abdominal aortic aneurysm ultrasound for men aged 65-75 who have ever smoked, regardless of quit date. The one-time AAA ultrasound is most appropriate given the client's age, gender, and smoking history, aligning with evidence-based prevention. Option A is incorrect as lung cancer CT screening requires quitting within 15 years; option C is inappropriate because routine stress tests are not recommended for asymptomatic CAD screening; option D is less suitable as colonoscopy intervals are typically 10 years for normal results, not every 2 years. Staying updated with preventive care guidelines ensures avoidance of unnecessary invasive procedures. USPSTF provides tailored recommendations for older adults. A transferable strategy is to review smoking history, age, and preferences to select low-risk, high-benefit screenings.
2. A 45-year-old man presents for a new primary care visit. He is asymptomatic, has no prior colorectal screening, and reports his father was diagnosed with colorectal cancer at age 54. He works two jobs and worries about time off for procedures. The nurse should recommend which preventive test based on the client's age and history?
   Answer: Begin colorectal cancer screening now (eg, colonoscopy) because of first-degree relative with early colorectal cancer This question tests understanding of preventive screening schedules in health promotion, emphasizing risk-adjusted colorectal cancer screening. USPSTF guidelines recommend starting colorectal cancer screening at age 45 for average-risk adults, but earlier (age 40 or 10 years before the relative's diagnosis) for those with a first-degree relative diagnosed before age 60. Beginning colorectal cancer screening now is most appropriate due to the client's age and father's diagnosis at age 54, placing him at increased risk. Option B is incorrect as screening should not be deferred to age 50 with this family history; option C is inappropriate because family history of colorectal cancer does not indicate PSA testing for prostate cancer; option D is less suitable as CT abdomen/pelvis is not a standard screening tool for colorectal cancer. Staying updated with preventive care guidelines is essential to identify high-risk individuals and prevent delays in detection. Guidelines from bodies like USPSTF help optimize screening intervals and methods. A transferable strategy is to evaluate family history details, client age, and barriers like work constraints to recommend timely, feasible screening options.
3. A 57-year-old man presents for a preventive visit. He has no urinary symptoms, but his brother was diagnosed with prostate cancer at age 60. He is worried and asks for "the best test" to catch prostate cancer early. The nurse should recommend which preventive test based on the client's age and history?
   Answer: Discuss prostate cancer screening with PSA testing using shared decision-making This question tests understanding of preventive screening schedules in health promotion, emphasizing prostate cancer screening. USPSTF guidelines recommend shared decision-making for PSA testing in men aged 55-69, particularly with family history increasing risk. Discussing PSA via shared decision-making is most appropriate due to the client's age and brother's diagnosis. Option B is incorrect as prostate MRI is not routine annual screening; option C is inappropriate because monthly PSA is excessive; option D is less suitable as screening is not deferred to 75. Staying updated with preventive care guidelines aids in weighing benefits and harms. USPSTF promotes individualized approaches. A transferable strategy is to incorporate age, family history, and client worries to guide prostate screening discussions.
4. A 50-year-old woman presents for a preventive visit. She has no symptoms, no family history of colorectal cancer, and has never been screened. She is concerned about taking time off work for colonoscopy and asks about alternatives. Which preventive measure is indicated for the client at this time?
   Answer: Initiate colorectal cancer screening now (eg, stool-based test or colonoscopy) This question tests understanding of preventive screening schedules in health promotion, focusing on colorectal cancer initiation. USPSTF guidelines recommend colorectal cancer screening for adults aged 45-75, with options like stool-based tests or colonoscopy for average-risk individuals. Initiating colorectal cancer screening now is most appropriate as the client is age 50 and unscreened, aligning with standard recommendations. Option B is incorrect as screening starts at 45-50, not deferred to 60; option C is inappropriate because colonoscopy is typically every 10 years for normal results, not annually; option D is less suitable as CT abdomen/pelvis is not a preferred screening method. Staying updated with preventive care guidelines allows for alternative options like stool tests to address barriers such as work. USPSTF emphasizes flexible strategies. A transferable strategy is to consider age, screening history, and preferences to initiate timely colorectal screening modalities.
5. A 63-year-old man comes for an annual wellness visit. He has type 2 diabetes and hypertension; he takes a statin and ACE inhibitor. He has no chest pain and asks whether he should get a "heart scan" to prevent a heart attack. Which preventive measure is indicated for the client at this time?
   Answer: Continue regular blood pressure and lipid screening/management as primary cardiovascular prevention This question tests understanding of preventive screening schedules in health promotion, emphasizing cardiovascular prevention in diabetics. USPSTF guidelines do not recommend routine imaging like CT angiography for asymptomatic CAD; instead, focus on risk factor management like blood pressure and lipids. Continuing BP and lipid screening/management is most appropriate as the client is asymptomatic with controlled risks. Option A is incorrect as coronary CT is not routine; option C is inappropriate because annual stress tests are not for all over 60; option D is less suitable as catheterization is invasive and not screening. Staying updated with preventive care guidelines prevents over-testing. USPSTF emphasizes primary prevention. A transferable strategy is to assess symptoms and comorbidities to recommend non-invasive cardiovascular risk management over screening tests.
6. A 23-year-old woman presents for a routine visit and requests confidential care. She is sexually active with multiple partners in the past year and reports inconsistent condom use; she is asymptomatic and worries about stigma if testing is documented. What is the most appropriate screening for the client's current health status?
   Answer: Annual screening for chlamydia and gonorrhea This question tests understanding of preventive screening schedules for sexually transmitted infections in high-risk young adults. Current guidelines recommend annual screening for chlamydia and gonorrhea in sexually active women under 25, with more frequent screening for those with risk factors like multiple partners or inconsistent condom use. The correct answer (A) appropriately recommends annual STI screening for this 23-year-old with multiple partners and inconsistent condom use. Waiting for symptoms (B) is inappropriate as many STIs are asymptomatic, syphilis screening only in pregnancy (C) misses opportunities for early detection and treatment, and hepatitis C screening every 6 months (D) is not the standard recommendation for all sexually active adults. Regular STI screening in high-risk populations prevents complications and transmission. When addressing confidentiality concerns, explain privacy protections and discuss secure methods for result delivery to maintain trust and encourage regular screening.
7. A 21-year-old woman presents for a routine visit. She is sexually active with one partner and has no symptoms. She says pelvic exams are uncomfortable and asks if she can delay cervical cancer screening. What is the most appropriate screening for the client's current health status?
   Answer: Begin cervical cancer screening now with cytology (Pap test) every 3 years This question tests understanding of preventive screening schedules in health promotion, particularly cervical cancer initiation. USPSTF guidelines recommend starting cervical cancer screening at age 21 with cytology every 3 years for women aged 21-29, regardless of sexual activity onset. Beginning Pap testing every 3 years now is most appropriate as the client is 21 and sexually active. Option B is incorrect because screening starts at 21, not delayed to 25; option C is inappropriate as co-testing is for ages 30+; option D is less suitable since HPV alone is an option for 30+, not annually from 21. Staying updated with preventive care guidelines addresses discomfort through education. USPSTF supports age-based starts. A transferable strategy is to consider age, sexual history, and preferences to initiate cervical screening intervals.
8. A 39-year-old woman presents for a preventive visit. She is asymptomatic and reports her sister was diagnosed with colorectal cancer at age 42; she is fearful of invasive tests and asks about noninvasive options. Which preventive measure is indicated for the client at this time?
   Answer: Colonoscopy now because a first-degree relative had early-onset colorectal cancer This question tests understanding of preventive screening schedules for colorectal cancer in younger individuals with significant family history. When a first-degree relative is diagnosed with colorectal cancer before age 50, screening should begin at age 40 or 10 years before the age at diagnosis of the youngest affected relative, whichever is earlier. The correct answer (B) appropriately recommends colonoscopy now, as the client's sister was diagnosed at 42, making screening indicated at age 32 (10 years earlier). Waiting until age 45 (A) would delay necessary screening, stool DNA testing every 10 years (C) is incorrect as the interval is typically 3 years and colonoscopy is preferred for high-risk individuals, and fecal occult blood testing once (D) is inadequate as it requires annual testing and colonoscopy is preferred for those with family history. Understanding early-onset colorectal cancer screening is increasingly important as incidence rises in younger adults. For clients with anxiety about invasive procedures, discuss the importance of colonoscopy for high-risk individuals while offering support and sedation options.
9. A 32-year-old pregnant client (G2P1) at 10 weeks' gestation presents for her first prenatal visit. She has a BMI of 33 kg/m² and a prior pregnancy with a 9 lb (4.1 kg) infant; she is worried because diabetes "runs in the family," and she has limited transportation for extra visits. Which screening should be prioritized for this client?
   Answer: Screen now for overt diabetes in early pregnancy due to risk factors (e.g., early glucose testing) This question tests understanding of preventive screening schedules for gestational diabetes in high-risk pregnant women. Current guidelines recommend early screening for overt diabetes in pregnant women with risk factors including obesity (BMI ≥30), prior macrosomic infant, and family history of diabetes. The correct answer (A) appropriately recommends screening now in early pregnancy for this client with multiple risk factors (BMI 33, prior 9 lb infant, family history). Delaying testing until 36-38 weeks (B) would miss the opportunity for early intervention, waiting for symptoms (C) is inappropriate as gestational diabetes is often asymptomatic, and monthly A1c testing (D) is excessive and not the standard approach for gestational diabetes screening. Early identification and management of gestational diabetes improves maternal and fetal outcomes. For high-risk pregnant women, perform early glucose testing and, if normal, repeat screening at 24-28 weeks as standard practice.
10. A 52-year-old woman (G2P2) comes to the clinic for an annual wellness visit. She has no symptoms, had a normal Pap/HPV co-test 3 years ago, and reports her mother was diagnosed with breast cancer at age 45. She is anxious about cancer due to her family history and asks what screening she should do now. Which screening should be prioritized for this client?
    Answer: Screening mammography now and then every 1–2 years based on shared decision-making This question tests understanding of preventive screening schedules in health promotion, focusing on age-appropriate and risk-based cancer screenings for women. Guidelines from organizations like the USPSTF recommend biennial mammography for women aged 50-74, with shared decision-making for those with family history of breast cancer in a first-degree relative under age 50. Screening mammography is the most appropriate because the client's age and maternal history of early breast cancer increase her risk, warranting initiation now and ongoing based on shared decision-making. Option A is incorrect as routine ovarian cancer screening with CA-125 and transvaginal ultrasound is not recommended due to lack of benefit and potential harms; option C is less appropriate as colorectal screening typically starts at age 45 for average risk, not deferred to 60; option D is incorrect because whole-body CT scans are not recommended for cancer screening due to radiation risks and low yield. Staying updated with preventive care guidelines is crucial as they evolve based on evidence to balance benefits and harms in diverse populations. Nurses should regularly review sources like USPSTF to provide accurate recommendations. A transferable strategy is to assess client age, family history, and personal risks to tailor screening plans that promote early detection while considering client preferences and barriers.
11. A 26-year-old woman presents for STI screening. She reports a new partner and inconsistent condom use; she has no symptoms. She is uninsured and asks for the most important tests to start with today. Which screening should be prioritized for this client?
    Answer: Chlamydia and gonorrhea screening This question tests understanding of preventive screening schedules in health promotion, focusing on STI screening in at-risk women. USPSTF guidelines recommend chlamydia and gonorrhea screening for sexually active women 25 and older with risk factors like new partners and inconsistent condoms. Chlamydia and gonorrhea screening is most appropriate given the client's risks and lack of symptoms. Option B is incorrect as bacterial vaginosis screening is not routine in asymptomatic women; option C is inappropriate because Pap is every 3-5 years from age 21, not annual; option D is less suitable as HSV serology is not routine. Staying updated with preventive care guidelines helps prioritize cost-effective tests. USPSTF guides risk-based STI care. A transferable strategy is to evaluate behavioral risks and insurance status to select essential screenings.
12. A 73-year-old woman presents for an annual exam. She is a current smoker and has hypertension; she is postmenopausal and had no prior fractures. She asks whether she should be screened for osteoporosis. She also notes she has limited transportation and prefers to combine appointments. The nurse should recommend which preventive test based on the client's age and history?
    Answer: DXA scan to screen for osteoporosis because she is age 65 or older This question tests understanding of preventive screening schedules in health promotion, focusing on osteoporosis in older women. USPSTF guidelines recommend DXA screening for all women aged 65 and older, with consideration of risks like smoking. A DXA scan is most appropriate due to the client's age and postmenopausal status. Option B is incorrect as screening is routine, not symptom-dependent; option C is inappropriate because bone scans are for metastasis, not osteoporosis; option D is less suitable as annual DXA is excessive. Staying updated with preventive care guidelines facilitates combining tests for convenience. USPSTF supports age-based screening. A transferable strategy is to consider age, risks, and logistics to recommend osteoporosis screening timing.
13. A 29-year-old man who has sex with men (MSM) comes for a routine checkup. He reports new partners and inconsistent condom use; he has no symptoms today. He expresses concern about confidentiality because he is not "out" to his family. What is the most appropriate screening for the client's current health status?
    Answer: Screen for HIV at least annually (and consider more frequent screening based on risk) This question tests understanding of preventive screening schedules in health promotion, specifically HIV screening in high-risk groups. CDC and USPSTF guidelines recommend at least annual HIV screening for individuals at increased risk, such as MSM with multiple partners and inconsistent condom use, with more frequent testing based on exposure. Annual HIV screening with consideration for more frequency is most appropriate given the client's sexual behaviors and risk profile. Option B is incorrect as screening should not wait for symptoms; option C is inappropriate because screening frequency is risk-based, not every 10 years; option D is less suitable as CD4 count is for monitoring, not initial screening. Staying updated with preventive care guidelines is crucial for confidentiality and early detection in vulnerable populations. CDC updates guide frequency adjustments. A transferable strategy is to evaluate risk behaviors and privacy concerns to recommend appropriate HIV testing intervals.
14. A 28-year-old pregnant client at 12 weeks' gestation has no past medical history and a normal BMI. She reports her sister had gestational diabetes, and she is worried about having it too. She has stable housing but limited prenatal visit availability due to transportation. What is the most appropriate screening for the client's current health status?
    Answer: Perform routine gestational diabetes screening at 24–28 weeks' gestation This question tests understanding of preventive screening schedules in health promotion, focusing on gestational diabetes in low-risk pregnancies. ACOG guidelines advise routine screening for gestational diabetes at 24-28 weeks' gestation for women without high-risk factors like obesity or prior gestational diabetes. Routine screening at 24-28 weeks is most appropriate as the client has a normal BMI and no personal history, despite family history not warranting early testing. Option B is incorrect because early screening is reserved for high-risk cases, not all pregnancies; option C is inappropriate as normal fasting glucose does not eliminate the need for standard screening; option D is less suitable since continuous glucose monitoring is not standard for screening. Staying updated with preventive care guidelines ensures appropriate timing to avoid unnecessary tests while addressing barriers like transportation. Sources like ACOG help tailor care to individual risk profiles. A transferable strategy is to assess risk factors and client concerns to schedule screenings that balance evidence-based recommendations with accessibility.
15. A 31-year-old pregnant client at 11 weeks' gestation has a BMI of 36 kg/m² and a history of polycystic ovary syndrome. She has no prior diagnosis of diabetes and is asymptomatic. She expresses fear of needles and requests to delay testing. Which screening should be prioritized for this client?
    Answer: Early screening for diabetes in pregnancy now due to high-risk factors (eg, obesity/PCOS), with repeat routine screening at 24–28 weeks if initial testing is normal This question tests understanding of preventive screening schedules in health promotion, specifically for gestational diabetes in pregnant clients with risk factors. Guidelines from organizations like the American College of Obstetricians and Gynecologists (ACOG) and the American Diabetes Association (ADA) recommend early screening for pregnant women with high-risk factors such as obesity (BMI ≥30 kg/m²) and polycystic ovary syndrome (PCOS), ideally at the first prenatal visit, regardless of gestational age. The correct answer, option A, is the most appropriate because it prioritizes immediate screening due to the client's risk factors, followed by routine rescreening at 24-28 weeks if initial results are normal, ensuring timely detection and management of gestational diabetes to prevent complications. Option B is incorrect as screening is indicated in the first trimester for high-risk clients; option C is inappropriate because screening should be proactive based on risk rather than waiting for symptoms; and option D is wrong as CT scans are not used for diabetes screening, which typically involves blood glucose tests. It is crucial for nurses to stay updated with preventive care guidelines, as they evolve based on evidence to optimize maternal and fetal outcomes. Regularly reviewing resources like ACOG and ADA updates ensures accurate application in clinical practice. A transferable strategy is to assess client-specific data, including age, BMI, medical history, and risk factors, to recommend evidence-based screenings while addressing client concerns like fear of needles through education and support.
16. A 28-year-old pregnant client at 9 weeks' gestation has no prior history of diabetes, BMI 24 kg/m², and no prior macrosomic infant. She expresses concern about fasting for tests due to nausea and asks when diabetes screening is typically done. The nurse should recommend which preventive test based on the client's age and history?
    Answer: Screen for gestational diabetes at 24–28 weeks' gestation This question tests understanding of preventive screening schedules for gestational diabetes in average-risk pregnant women. Current guidelines recommend universal screening for gestational diabetes at 24-28 weeks' gestation for all pregnant women without pre-existing diabetes. The correct answer (B) appropriately recommends screening at 24-28 weeks for this client with no risk factors (normal BMI, no history of macrosomia). No screening (A) is incorrect as universal screening is recommended, postpartum screening only (C) misses the opportunity to diagnose and treat gestational diabetes during pregnancy, and weekly screening from 12 weeks (D) is excessive and not evidence-based. Understanding standard prenatal screening timelines ensures appropriate detection and management of gestational diabetes. When counseling patients about gestational diabetes screening, explain that the 24-28 week timeframe balances early detection with test accuracy while allowing flexibility for those with morning sickness concerns.
17. A 24-year-old man presents to a community clinic. He reports multiple partners and inconsistent condom use; he has no symptoms. He is concerned about cost and asks which STI screening is most important to do routinely. Which screening should be prioritized for this client?
    Answer: HIV screening (and risk-based screening for other STIs such as syphilis, gonorrhea, and chlamydia based on exposure) This question tests understanding of preventive screening schedules in health promotion, focusing on STI screening in young men. CDC guidelines recommend HIV screening at least annually for sexually active individuals with risks like multiple partners, plus risk-based testing for other STIs. HIV and risk-based STI screening is most appropriate given the client's behaviors and asymptomatic status. Option B is incorrect as routine HSV serology is not recommended; option C is inappropriate for men as Pap tests are for cervical screening; option D is less suitable since asymptomatic bacteriuria screening is not routine. Staying updated with preventive care guidelines optimizes cost-effective testing. CDC supports high-risk protocols. A transferable strategy is to assess sexual practices and costs to prioritize key STI screenings.
18. A 34-year-old pregnant client at 9 weeks' gestation has chronic hypertension and is taking labetalol. She has no history of diabetes and her BMI is 23 kg/m². She reports significant stress and limited family support. Which preventive measure is indicated for the client at this time?
    Answer: Plan routine gestational diabetes screening at 24–28 weeks if no additional high-risk features are present This question tests understanding of preventive screening schedules in health promotion, specifically gestational diabetes timing. ACOG guidelines recommend routine screening at 24-28 weeks for pregnant women without high-risk factors, as chronic hypertension alone does not necessitate early testing unless accompanied by other risks like obesity. Planning routine screening at 24-28 weeks is most appropriate given the client's normal BMI and lack of diabetes history. Option A is incorrect as chronic hypertension does not independently require first-trimester testing; option C is inappropriate because screening is standard regardless of weight; option D is less suitable as weekly random glucose is not standard. Staying updated with preventive care guidelines addresses stressors like limited support. ACOG ensures evidence-based prenatal care. A transferable strategy is to assess specific risk factors and psychosocial elements to time gestational diabetes screening appropriately.
19. A 55-year-old woman with no symptoms reports her father had melanoma and her mother had colon cancer at age 72. She asks what cancer screening she should focus on now. She works outdoors and has had frequent sunburns. Which screening should be prioritized for this client?
    Answer: Initiate colorectal cancer screening now (if not already done) using an approved screening strategy This question tests understanding of preventive screening schedules in health promotion, particularly prioritizing cancer screenings. USPSTF guidelines recommend colorectal cancer screening starting at age 45 for average-risk adults, with no routine screening for pancreatic or ovarian cancer based on family history alone. Initiating colorectal cancer screening now is most appropriate as the client is 55 and potentially unscreened, with melanoma family history warranting skin checks but not overriding CRC priority. Option B is incorrect as pancreatic MRI is not routine; option C is inappropriate because CA-125 is not recommended; option D is less suitable as whole-body skin MRI is not standard. Staying updated with preventive care guidelines integrates occupational risks like sun exposure. USPSTF prioritizes evidence-based tests. A transferable strategy is to evaluate family history, age, and lifestyle to focus on high-priority screenings like CRC.
20. A 68-year-old man with hyperlipidemia and a 30 pack-year smoking history quit smoking 8 years ago. He is asymptomatic and says he avoids clinics due to mistrust from prior experiences; he will agree to one high-value screening today. Which screening should be prioritized for this client?
    Answer: Low-dose CT of the chest annually to screen for lung cancer This question tests understanding of preventive screening schedules for lung cancer in high-risk individuals. Current USPSTF guidelines recommend annual low-dose CT screening for adults aged 50-80 with a 20+ pack-year smoking history who currently smoke or quit within the past 15 years. The correct answer (A) appropriately recommends low-dose CT screening for this 68-year-old with 30 pack-year history who quit 8 years ago. Chest x-ray (B) and sputum cytology (C) are not recommended for lung cancer screening due to lack of mortality benefit, and whole-body MRI (D) is not an evidence-based screening approach and involves unnecessary cost and potential false positives. Understanding lung cancer screening criteria helps identify those most likely to benefit from early detection. For patients with healthcare mistrust, emphasize that lung cancer screening with low-dose CT has been proven to reduce mortality in high-risk individuals and can be life-saving.

Start this quiz